1. Home
  2. OWL vs ELAN Comparison

OWL vs ELAN Comparison

Compare OWL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OWL
  • ELAN
  • Stock Information
  • Founded
  • OWL 2020
  • ELAN 1954
  • Country
  • OWL United States
  • ELAN United States
  • Employees
  • OWL N/A
  • ELAN N/A
  • Industry
  • OWL Investment Managers
  • ELAN Biotechnology: Pharmaceutical Preparations
  • Sector
  • OWL Finance
  • ELAN Health Care
  • Exchange
  • OWL Nasdaq
  • ELAN Nasdaq
  • Market Cap
  • OWL 10.6B
  • ELAN 10.3B
  • IPO Year
  • OWL N/A
  • ELAN 2018
  • Fundamental
  • Price
  • OWL $16.59
  • ELAN $20.41
  • Analyst Decision
  • OWL Buy
  • ELAN Buy
  • Analyst Count
  • OWL 15
  • ELAN 8
  • Target Price
  • OWL $23.75
  • ELAN $19.14
  • AVG Volume (30 Days)
  • OWL 10.6M
  • ELAN 5.4M
  • Earning Date
  • OWL 10-30-2025
  • ELAN 11-05-2025
  • Dividend Yield
  • OWL 5.59%
  • ELAN N/A
  • EPS Growth
  • OWL 20.13
  • ELAN N/A
  • EPS
  • OWL 0.11
  • ELAN 0.88
  • Revenue
  • OWL $2,618,831,000.00
  • ELAN $4,484,000,000.00
  • Revenue This Year
  • OWL $17.28
  • ELAN $5.72
  • Revenue Next Year
  • OWL $22.36
  • ELAN $4.88
  • P/E Ratio
  • OWL $141.11
  • ELAN $23.36
  • Revenue Growth
  • OWL 31.81
  • ELAN N/A
  • 52 Week Low
  • OWL $14.55
  • ELAN $8.02
  • 52 Week High
  • OWL $26.73
  • ELAN $21.76
  • Technical
  • Relative Strength Index (RSI)
  • OWL 32.13
  • ELAN 68.02
  • Support Level
  • OWL $16.03
  • ELAN $20.39
  • Resistance Level
  • OWL $16.83
  • ELAN $21.76
  • Average True Range (ATR)
  • OWL 0.58
  • ELAN 0.58
  • MACD
  • OWL -0.14
  • ELAN 0.03
  • Stochastic Oscillator
  • OWL 9.57
  • ELAN 59.15

About OWL Blue Owl Capital Inc.

Blue Owl Capital Inc is an alternative asset management firm. The company deploys private capital across Credit, GP Strategic Capital, and Real Estate platforms on behalf of institutional and private wealth clients. The company conducts its operations through Blue Owl Capital Holdings LP (Blue Owl Holdings) and Blue Owl Capital Carry LP (Blue Owl Carry). Its investor base includes a diversified mix of institutional investors, including public and private pension funds, endowments, foundations, family offices, private banks, high-net-worth individuals, asset managers, and insurance companies. The company generates substantially all of its revenues in the United States.

About ELAN Elanco Animal Health Incorporated

Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.

Share on Social Networks: